Form 4 for MRNA Moderna
Accepted 2026-06-08 16:30:19 ET · period of report 2026-06-05 · accession 0001682852-26-000117 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-08 16:30 | 2026-06-05 | MRNA | Mock James M | CFO | M - OptEx | — | +11.8K | 71.4K | +20% | — |
| D | 2026-06-08 16:30 | 2026-06-05 | MRNA | Mock James M | CFO | F - Tax | $51.59 | -5,705 | 65.7K | -8% | -$294.3K |
| D | 2026-06-08 16:30 | 2026-06-05 | MRNA | Mock James M | CFO | M - OptEx | $0.00 | -11.8K | 118.0K | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-05 | M | A | 11,798 | — | 71,392 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2026-06-05 | F | D | 5,705 | $51.59 | 65,687 | D | — | — | (F2) Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. |
| 3 | Derivative | Restricted Stock Units | 2026-06-05 | M | D | 11,798 | $0.00 | 117,976 | D | — · — to — | 11,798 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F1) Restricted stock units convert into common stock on a one-for-one basis. (F3) 25% of the shares subject to this restricted stock unit award vested on December 5, 2025, with the remainder vesting in twelve (12) equal quarterly installments thereafter. (F3) 25% of the shares subject to this restricted stock unit award vested on December 5, 2025, with the remainder vesting in twelve (12) equal quarterly installments thereafter. |